Tragic outcome to new pain relief drug trial in the news. One healthy participant is brain dead, 5 others hospitalized in Phase 1 clinical trial. The drug was a FAAH inhibitor called BIA 10-2474, created to boost anandamide which affects the brain's cannabinoid receptors, and eases pain and anxiety (other FAAH inhibitors are also being studied for MS) That's right. Pharma, trying to patent a new drug for something which already exists and doesn't kill people, called marijuana. Heartbreaking and unnecessary. Joan

By John Brosky and Cormac Sheridan, Staff Writers PARIS – One volunteer for a phase I trial of novel compound BIA 10-2474, designed to target pain relief by acting on cannabinoid receptors, has been p